Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades

175
Comment
Favorite

Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades

Motley Fool2022-10-03

Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

175

Report

Comment

Vincent1968
·2022-10-03
Ok
Reply
Like
Report
Jackwoft
·2022-10-03
👍🏻
Reply
2
Report
Zwei2
·2022-10-03
K
Reply
1
Report
KTX
·2022-10-03
Like pls
Reply
4
Report
JosephPhang
·2022-10-03
tq
Reply
1
Report
weifa
·2022-10-03
ok
Reply
3
Report
JeffTai
·2022-10-03
Ok
Reply
3
Report
Bonghanhuei
·2022-10-03
Ok
Reply
6
Report
VivianChua
·2022-10-03
Ok
Reply
4
Report
bostonxsgp
·2022-10-03
hm
Reply
7
Report
Fold Replies
- bostonxsgp:
  oo
  2022-10-03
  Reply
  Report
MBE
·2022-10-03
Not sure
Reply
5
Report
Fold Replies
- JeffTai:
  ok
  2022-10-03
  Reply
  Report
BeBob
·2022-10-03
Like
Reply
9
Report
Fold Replies
- Bonghanhuei:
  ok
  2022-10-03
  Reply
  Report
- kctan:
  Ok
  2022-10-03
  Reply
  Report
- FunnyFun:
  Ok
  2022-10-03
  Reply
  Report
BeBob
·2022-10-03
Like
Reply
5
Report
Fold Replies
- C1238:
  Co
  2022-10-03
  Reply
  Report
- BeBob:
  14
  2022-10-03
  Reply
  Report
- BeBob:
  13
  2022-10-03
  Reply
  Report
View more 2 comments
kohce
·2022-10-03
Ok
Reply
5
Report
ChrisLiew
·2022-10-03
Like pls
Reply
6
Report
TigerEye
·2022-10-03
Cool
Reply
2
Report
YongJie
·2022-10-03
Wa
Reply
3
Report
Fold Replies
- YongJie:
  Wa
  2022-10-03
  Reply
  Report
boonchek
·2022-10-03
Ok
Reply
4
Report
Quantum Leap
·2022-10-03
you must be joking, come lah, buy Ascendas and Mapletree dividends GOD family. At end of 20 years, you will become one of us, the chosen F.I.R.E Gods
Reply
4
Report
Fold Replies
- Quantum Leap:
  Only time will tell. most importantly I will see you on the moon
  2022-10-03
  Reply
  Report
- Pluto891:
  really?
  2022-10-03
  Reply
  Report
dancingbook
·2022-10-03
K
Reply
3
Report
Fold Replies
- boonchek:
  Ok
  2022-10-03
  Reply
  Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2272601907?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-10-03 14:49","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2272601907","market":"us","top_or_hot":-1,"title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","media":"Motley Fool","content":"<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Source Link</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"TGT","symbol_name":"塔吉特","start_time":0,"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","article_id":"2272601907","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","pubTimestamp":1664779787,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"Dividend stocks could be your best friend right now.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"TGT":"塔吉特","BK4550":"红杉资本持仓","PFE":"辉瑞","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4548":"巴美列捷福持仓","BK4535":"淡马锡持仓","BK4551":"寇图资本持仓","BK4534":"瑞士信贷持仓","BK4581":"高盛持仓","BK4139":"生物科技","BK4568":"美国抗疫概念"},"translate_title":"拿到1000美元？2购买并持有数十年的股息股票","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":0.9,"TGT":0.9},"content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","kind":null,"is_publish_news":null,"is_publish_highlight":null,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"symbols":[],"gpt_button":1},"commentList":[{"id":9912890341,"gmtCreate":1664786892483,"gmtModify":1676537508447,"author":{"id":"3586393315819735","authorId":"3586393315819735","name":"Vincent1968","avatar":"https://community-static.tradeup.com/news/7f106edb1e06baf3c68462c050422f46","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912890341","repostId":2272601907,"repostType":4,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9912804461,"gmtCreate":1664786304853,"gmtModify":1676537508393,"author":{"id":"4127480689652162","authorId":"4127480689652162","name":"Jackwoft","avatar":"https://community-static.tradeup.com/news/dcd4729447890030536762f5aedd116c","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":0},"htmlText":"👍🏻","listText":"👍🏻","text":"👍🏻","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912804461","repostId":2272601907,"repostType":4,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9912174787,"gmtCreate":1664784017549,"gmtModify":1676537507981,"author":{"id":"3580356429010047","authorId":"3580356429010047","name":"Zwei2","avatar":"https://static.tigerbbs.com/9d0132a4cde9155d859c3873325d194e","vip":1,"hat":"https://static.tigerbbs.com/646756f1284a5a6480ed02cc4fa7d1d2","crmLevel":6,"crmLevelSwitch":0},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912174787","repostId":2272601907,"repostType":4,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9912172340,"gmtCreate":1664783249780,"gmtModify":1676537507727,"author":{"id":"3571482211918385","authorId":"3571482211918385","name":"KTX","avatar":"https://static.tigerbbs.com/f7d2d6c9788fbae7ed024ed5ba7c58e4","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like pls&nbsp;","listText":"Like pls&nbsp;","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912172340","repostId":2272601907,"repostType":4,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9912176665,"gmtCreate":1664783204157,"gmtModify":1676537507710,"author":{"id":"4107258358900820","authorId":"4107258358900820","name":"JosephPhang","avatar":"https://static.itradeup.com/news/e5c94ae5ff687e6be2e6ff332205ace2","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"tq","listText":"tq","text":"tq","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912176665","repostId":2272601907,"repostType":2,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9912176166,"gmtCreate":1664783188855,"gmtModify":1676537507705,"author":{"id":"4089108952462310","authorId":"4089108952462310","name":"weifa","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":5,"crmLevelSwitch":0},"htmlText":"ok","listText":"ok","text":"ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912176166","repostId":2272601907,"repostType":2,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9912171650,"gmtCreate":1664782681470,"gmtModify":1676537507636,"author":{"id":"3581504334066898","authorId":"3581504334066898","name":"JeffTai","avatar":"https://static.tigerbbs.com/eaf357935d6e8ef3744f3d94312f0a64","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912171650","repostId":2272601907,"repostType":4,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9912173428,"gmtCreate":1664782484965,"gmtModify":1676537507610,"author":{"id":"3581734044994294","authorId":"3581734044994294","name":"Bonghanhuei","avatar":"https://static.tigerbbs.com/c688d7ad40c511adab3aa29cdc4befc5","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912173428","repostId":2272601907,"repostType":4,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9912179394,"gmtCreate":1664781742918,"gmtModify":1676537507554,"author":{"id":"3580011914778910","authorId":"3580011914778910","name":"VivianChua","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":5,"crmLevelSwitch":1},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912179394","repostId":2272601907,"repostType":4,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9912170788,"gmtCreate":1664781652344,"gmtModify":1676537507545,"author":{"id":"3584157491931754","authorId":"3584157491931754","name":"bostonxsgp","avatar":"https://static.tigerbbs.com/55d82efabeabddb18cc2d6ca7a71a36f","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"hm","listText":"hm","text":"hm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9912170788","repostId":2272601907,"repostType":4,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104199071,"gmtCreate":1664781660408,"gmtModify":1664781663618,"authorId":3584157491931754,"author":{"id":3584157491931754,"authorId":3584157491931754,"name":"bostonxsgp","avatar":"https://static.tigerbbs.com/55d82efabeabddb18cc2d6ca7a71a36f","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"60.64%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9912170788,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">oo</span>","text":"<span class=\"s1\">oo</span>","html":"<span class=\"s1\">oo</span>"}],"langContent":"EN"},{"id":9912170977,"gmtCreate":1664781414499,"gmtModify":1676537507514,"author":{"id":"3586406638423368","authorId":"3586406638423368","name":"MBE","avatar":"https://static.tigerbbs.com/819dcae50fc62e5a41b7d625052bd116","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Not sure&nbsp;","listText":"Not sure&nbsp;","text":"Not sure","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9912170977","repostId":2272601907,"repostType":4,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104199166,"gmtCreate":1664782693591,"gmtModify":1664782697012,"authorId":3581504334066898,"author":{"id":3581504334066898,"authorId":3581504334066898,"name":"JeffTai","avatar":"https://static.tigerbbs.com/eaf357935d6e8ef3744f3d94312f0a64","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9912170977,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"}],"langContent":"EN"},{"id":9912147006,"gmtCreate":1664781171005,"gmtModify":1676537507476,"author":{"id":"3585307651801295","authorId":"3585307651801295","name":"BeBob","avatar":"https://static.tigerbbs.com/4c7fb1588c34a61b54c3059c16e50b4e","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/9912147006","repostId":2272601907,"repostType":4,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104199127,"gmtCreate":1664782492750,"gmtModify":1664782495970,"authorId":3581734044994294,"author":{"id":3581734044994294,"authorId":3581734044994294,"name":"Bonghanhuei","avatar":"https://static.tigerbbs.com/c688d7ad40c511adab3aa29cdc4befc5","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9912147006,"type":1,"supId":0,"prevId":0,"content":"ok","text":"ok","html":"ok"},{"id":104199077,"gmtCreate":1664781735775,"gmtModify":1664781738998,"authorId":3576831123463310,"author":{"id":3576831123463310,"authorId":3576831123463310,"name":"kctan","avatar":"https://static.tigerbbs.com/f1770830f8c002db55c8aadca0939107","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9912147006,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Ok</span>","text":"<span class=\"s1\">Ok</span>","html":"<span class=\"s1\">Ok</span>"},{"id":104199045,"gmtCreate":1664781395542,"gmtModify":1664781398721,"authorId":3581664026895626,"author":{"id":3581664026895626,"authorId":3581664026895626,"name":"FunnyFun","avatar":"https://static.tigerbbs.com/e07aca58746125ec6ef6115042d363e9","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.01.12","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9912147006,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Ok</span>","text":"<span class=\"s1\">Ok</span>","html":"<span class=\"s1\">Ok</span>"}],"langContent":"EN"},{"id":9912144734,"gmtCreate":1664781164428,"gmtModify":1676537507475,"author":{"id":"3585307651801295","authorId":"3585307651801295","name":"BeBob","avatar":"https://static.tigerbbs.com/4c7fb1588c34a61b54c3059c16e50b4e","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":16,"repostSize":0,"link":"https://ttm.financial/post/9912144734","repostId":2272601907,"repostType":4,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104199048,"gmtCreate":1664781405649,"gmtModify":1664781408768,"authorId":4088591126250580,"author":{"id":4088591126250580,"authorId":4088591126250580,"name":"C1238","avatar":"https://static.tigerbbs.com/1c3415ee92c7e6c23d07e6173daae4d7","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.04.25","exceedPercentage":"60.62%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9912144734,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Co</span>","text":"<span class=\"s1\">Co</span>","html":"<span class=\"s1\">Co</span>"},{"id":104199027,"gmtCreate":1664781276214,"gmtModify":1664781279589,"authorId":3585307651801295,"author":{"id":3585307651801295,"authorId":3585307651801295,"name":"BeBob","avatar":"https://static.tigerbbs.com/4c7fb1588c34a61b54c3059c16e50b4e","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.11","exceedPercentage":"60.35%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9912144734,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">14</span>","text":"<span class=\"s1\">14</span>","html":"<span class=\"s1\">14</span>"},{"id":104199025,"gmtCreate":1664781266789,"gmtModify":1664781269985,"authorId":3585307651801295,"author":{"id":3585307651801295,"authorId":3585307651801295,"name":"BeBob","avatar":"https://static.tigerbbs.com/4c7fb1588c34a61b54c3059c16e50b4e","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.11","exceedPercentage":"60.35%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9912144734,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">13</span>","text":"<span class=\"s1\">13</span>","html":"<span class=\"s1\">13</span>"},{"id":104199024,"gmtCreate":1664781259635,"gmtModify":1664781262955,"authorId":3585307651801295,"author":{"id":3585307651801295,"authorId":3585307651801295,"name":"BeBob","avatar":"https://static.tigerbbs.com/4c7fb1588c34a61b54c3059c16e50b4e","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.11","exceedPercentage":"60.35%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9912144734,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">12</span>","text":"<span class=\"s1\">12</span>","html":"<span class=\"s1\">12</span>"},{"id":104199021,"gmtCreate":1664781252952,"gmtModify":1664781256605,"authorId":3585307651801295,"author":{"id":3585307651801295,"authorId":3585307651801295,"name":"BeBob","avatar":"https://static.tigerbbs.com/4c7fb1588c34a61b54c3059c16e50b4e","vip":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.11","exceedPercentage":"60.35%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9912144734,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">11</span>","text":"<span class=\"s1\">11</span>","html":"<span class=\"s1\">11</span>"}],"langContent":"EN"},{"id":9912144239,"gmtCreate":1664781111821,"gmtModify":1676537507467,"author":{"id":"3583987888271599","authorId":"3583987888271599","name":"kohce","avatar":"https://static.tigerbbs.com/c1dc0e6992a7bb828ab6c53c5aebf56a","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912144239","repostId":2272601907,"repostType":4,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9912144058,"gmtCreate":1664780982574,"gmtModify":1676537507412,"author":{"id":"3580393689769738","authorId":"3580393689769738","name":"ChrisLiew","avatar":"https://static.tigerbbs.com/35b3b9b772013ce79f9f4c5318d46fa7","vip":1,"hat":"https://static.tigerbbs.com/f84859c65fc2d7681e28f6b8e9b0535a","crmLevel":2,"crmLevelSwitch":1},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912144058","repostId":2272601907,"repostType":4,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9912145746,"gmtCreate":1664780836485,"gmtModify":1676537507411,"author":{"id":"4110119270548472","authorId":"4110119270548472","name":"TigerEye","avatar":"https://community-static.tradeup.com/news/c510165e512da25b8a7521d146874ef1","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Cool","listText":"Cool","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912145746","repostId":2272601907,"repostType":2,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9912145915,"gmtCreate":1664780622137,"gmtModify":1676537507372,"author":{"id":"3562030717219265","authorId":"3562030717219265","name":"YongJie","avatar":"https://static.tigerbbs.com/b62394bc1f2e9ceb953c1723f0bb72f2","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":4,"crmLevelSwitch":1},"htmlText":"Wa","listText":"Wa","text":"Wa","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9912145915","repostId":2272601907,"repostType":4,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104198960,"gmtCreate":1664780629578,"gmtModify":1664780633064,"authorId":3562030717219265,"author":{"id":3562030717219265,"authorId":3562030717219265,"name":"YongJie","avatar":"https://static.tigerbbs.com/b62394bc1f2e9ceb953c1723f0bb72f2","vip":1,"crmLevel":4,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9912145915,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Wa</span>","text":"<span class=\"s1\">Wa</span>","html":"<span class=\"s1\">Wa</span>"}],"langContent":"EN"},{"id":9912145045,"gmtCreate":1664780616887,"gmtModify":1676537507366,"author":{"id":"3582036219515358","authorId":"3582036219515358","name":"boonchek","avatar":"https://static.tigerbbs.com/c615abbfde8feafcbdd8e88179f1e152","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":3,"crmLevelSwitch":0},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9912145045","repostId":2272601907,"repostType":4,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9912142590,"gmtCreate":1664780522411,"gmtModify":1676537507357,"author":{"id":"3571890748169729","authorId":"3571890748169729","name":"Quantum Leap","avatar":"https://community-static.tradeup.com/news/62c1a0916e804092ec6476da360446aa","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":5,"crmLevelSwitch":0},"htmlText":"you must be joking, come lah, buy Ascendas and Mapletree dividends GOD family. At end of 20 years, you will become one of us, the chosen F.I.R.E Gods","listText":"you must be joking, come lah, buy Ascendas and Mapletree dividends GOD family. At end of 20 years, you will become one of us, the chosen F.I.R.E Gods","text":"you must be joking, come lah, buy Ascendas and Mapletree dividends GOD family. At end of 20 years, you will become one of us, the chosen F.I.R.E Gods","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/9912142590","repostId":2272601907,"repostType":2,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104200141,"gmtCreate":1664790907680,"gmtModify":1664790912049,"authorId":3571890748169729,"author":{"id":3571890748169729,"authorId":3571890748169729,"name":"Quantum Leap","avatar":"https://community-static.tradeup.com/news/62c1a0916e804092ec6476da360446aa","vip":1,"currentWearingBadge":{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.05.09","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1001},"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9912142590,"type":1,"supId":104199553,"prevId":0,"content":"<span class=\"s1\">Only time will tell. most importantly<span class=\"Apple-converted-space\">  </span>I will see you on the moon<span class=\"Apple-converted-space\"> </span></span>","text":"<span class=\"s1\">Only time will tell. most importantly<span class=\"Apple-converted-space\">  </span>I will see you on the moon<span class=\"Apple-converted-space\"> </span></span>","html":"<span class=\"s1\">Only time will tell. most importantly<span class=\"Apple-converted-space\">  </span>I will see you on the moon<span class=\"Apple-converted-space\"> </span></span>"},{"id":104199553,"gmtCreate":1664784870458,"gmtModify":1664784874486,"authorId":3581937910767045,"author":{"id":3581937910767045,"authorId":3581937910767045,"name":"Pluto891","avatar":"https://static.tigerbbs.com/c9963f2ef3d3ad2aff28340461d3d6d0","vip":1,"currentWearingBadge":{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9912142590,"type":1,"supId":0,"prevId":0,"content":"really?","text":"really?","html":"really?"}],"langContent":"EN"},{"id":9912142288,"gmtCreate":1664780504044,"gmtModify":1676537507356,"author":{"id":"4126408722762182","authorId":"4126408722762182","name":"dancingbook","avatar":"https://community-static.tradeup.com/news/8167225b10da952511304cb8496e5d08","vip":1,"crmLevel":3,"crmLevelSwitch":0},"htmlText":"K","listText":"K","text":"K","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9912142288","repostId":2272601907,"repostType":2,"repost":{"id":"2272601907","pubTimestamp":1664779787,"share":"https://www.laohu8.com/m/news/2272601907?lang=&edition=full","pubTime":"2022-10-03 14:49","market":"us","language":"en","title":"Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades","url":"https://stock-news.laohu8.com/highlight/detail?id=2272601907","media":"Motley Fool","summary":"Dividend stocks could be your best friend right now.","content":"<html><head></head><body><p>Dividend stocks are a must-have for any investor&#39;s portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.</p><p>Let&#39;s take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.</p><h2>1. <a href=\"https://laohu8.com/S/PFE\">Pfizer</a></h2><p>With a yield of 3.6%, <a href=\"https://laohu8.com/S/PFE\">Pfizer</a>&#39;s dividend more than outpaces that of the average stock trading on the <b>S&amp;P 500</b>, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.</p><p>To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.</p><p>There&#39;s no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer&#39;s top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It&#39;s inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.</p><p>But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it&#39;s using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.</p><p>The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.</p><h2>2. <a href=\"https://laohu8.com/S/TGT\">Target</a></h2><p><a href=\"https://laohu8.com/S/TGT\">Target </a> has such an impressive history of paying and raising its dividend that it&#39;s a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.</p><p>While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it&#39;s important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target&#39;s top and bottom line, the company remains a staple in consumers&#39; daily lives, and that&#39;s not going to change over the long term.</p><p>Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.</p><p>And in the company&#39;s most recent quarterly report, management noted that Target &#34;reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.&#34; This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Got $1,000? 2 Dividend Stocks to Buy and Hold for Decades</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGot $1,000? 2 Dividend Stocks to Buy and Hold for Decades\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-10-03 14:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4533":"AQR资本管理(全球第二大对冲基金)","BK4581":"高盛持仓","TGT":"塔吉特","BK4568":"美国抗疫概念","BK4551":"寇图资本持仓","PFE":"辉瑞","BK4548":"巴美列捷福持仓","BK4550":"红杉资本持仓","BK4535":"淡马锡持仓","BK4534":"瑞士信贷持仓","BK4139":"生物科技"},"source_url":"https://www.fool.com/investing/2022/10/02/got-1000-2-dividend-stocks-buy-and-hold-decades/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2272601907","content_text":"Dividend stocks are a must-have for any investor's portfolio in any market environment. With extreme volatility shaking the markets currently and stocks across sectors seeing share prices rise and fall from one day to the next, investing in quality companies with a commitment to paying and raising their dividends can provide peace of mind and maximize your portfolio returns, even in uncertain times.Let's take a look at two powerhouse dividend stocks you can buy and hold for decades if you have $1,000 to invest in the market right now.1. PfizerWith a yield of 3.6%, Pfizer's dividend more than outpaces that of the average stock trading on the S&P 500, which is around 2%. The pharmaceutical giant has paid a dividend since 1989, and has increased its dividend every year for a decade and counting.To put those numbers in perspective, Pfizer has increased its dividend by more than 80% over the trailing 10-year period. The stock has also delivered a total return of approximately 172% during this window. And Pfizer returned $4.5 billion in cash through shareholder dividends in the first six months of 2022 alone.There's no denying the huge effect that the success of COVID-19 vaccine Comirnaty and oral antiviral pill Paxlovid have had on Pfizer's top and bottom lines. In the most recent quarter, revenue jumped 47% year over year, while net income and diluted earnings per share rose 78% and 77%, respectively. It's inevitable that these numbers will start to decline at some point as COVID-19 becomes increasingly endemic.But Pfizer has so much more in its portfolio and pipeline than just its COVID-19 products. Blockbuster drugs like Eliquis and Ibrance raked in combined sales of roughly $3 billion in the second quarter alone. Plus, Pfizer has accumulated a significant cash stockpile that it's using in highly strategic ways, such as in its acquisition of Arena Pharmaceuticals and upcoming purchase of Biohaven Pharmaceuticals.The company also continues to invest heavily in research and development for its promising pipeline, which features drugs targeting everything from cancers like prostate cancer and metastatic breast cancer to various rare diseases like sickle cell disease and hemophilia. All of this bodes well for a long runway of growth for Pfizer, and long-term buy-and-hold investors can reap the rewards.2. TargetTarget  has such an impressive history of paying and raising its dividend that it's a member of the exclusive club known as Dividend Kings. It currently yields 2.8%. The company has raised its dividend every year for 51 years and counting. Over the past five years, Target has increased its dividend by more than 70%, delivering a total return to shareholders of 185%.While some investors may be concerned about potential near-term headwinds for Target, given fears that people may pull back on spending in the coming months, it's important to take a step back and look at the bigger picture. While short-term spending trends may indeed affect Target's top and bottom line, the company remains a staple in consumers' daily lives, and that's not going to change over the long term.Shoppers still rely on Target for a range of essential and non-essential product needs. In the second quarter, while comparable sales rose just 2.6% year over year, digital comparable sales rose 9% and same day services rose 11%. Target just announced that it still intends to hire 100,000 workers for the upcoming holiday season, just as it usually does.And in the company's most recent quarterly report, management noted that Target \"reduced its inventory exposure in discretionary categories while investing in rapidly growing frequency categories. Additionally, Fall season receipts in discretionary categories were reduced by more than $1.5 billion.\" This realigned focus on essential items bodes well for Target as it navigates the current environment, offloads excess inventory, and moves back toward profitability.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":104198959,"gmtCreate":1664780624179,"gmtModify":1664780627636,"authorId":3582036219515358,"author":{"id":3582036219515358,"authorId":3582036219515358,"name":"boonchek","avatar":"https://static.tigerbbs.com/c615abbfde8feafcbdd8e88179f1e152","vip":1,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":"80.54%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1100},"crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":9912142288,"type":1,"supId":0,"prevId":0,"content":"<span class=\"s1\">Ok</span>","text":"<span class=\"s1\">Ok</span>","html":"<span class=\"s1\">Ok</span>"}],"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":175,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}